Skip to main content

Table 7 Associations between adverse outcomes and sarcopenia critera in the total sample of 70 and 85 year-olds

From: Comparison of the 2010 and 2019 diagnostic criteria for sarcopenia by the European Working Group on Sarcopenia in Older People (EWGSOP) in two cohorts of Swedish older adults

Sarcopenia criteria

All-cause mortality

ADL dependencea

HR (95%CI)b

P

OR (95%CI)b

P

Individual criteria (cut-off)c

 Hand grip strength (T-score − 2.0)

1.9 (1.0–3.9)

0.064

1.4 (0.9–2.1)

0.09

 Hand grip strength (T-score − 2.5)

1.6 (0.7–3.3)

0.24

1.5 (1.0–2.4)

0.08

 Muscle mass (T-score − 2.0)

1.4 (0.7–2.6)

0.34

1.2 (0.8–1.8)

0.44

 Muscle mass (T-score − 2.5)

1.8 (0.9–3.7)

0.08

1.5 (0.9–2.5)

0.09

 Muscle mass (EWGSOP1)c

1.4 (0.7–2.6)

0.32

1.2 (0.8–1.9)

0.35

 Muscle mass (EWGSOP2)c

1.7 (0.9–3.2)

0.13

1.2 (0.8–1.9)

0.45

 Gait speed (T-score − 2.0)

2.1 (1.1–4.0)

0.026

3.9 (2.6–6.0)

< 0.001

 Gait speed (T-score − 2.5)

2.3 (1.2–4.6)

0.017

6.0 (3.6–10.0)

< 0.001

 Gait speed (< 0.8 m/s)

2.5 (1.0–6.2)

0.042

9.3 (3.9–21.9)

< 0.001

EWGSOP (cut-off)

 1 (T-score − 2.0)

1.6 (0.8–3.3)

0.18

1.5 (0.9–2.4)

0.10

 1 (T-score − 2.5)

2.8 (1.3–6.0)

0.009

2.2 (1.2–4.1)

0.012

 2 (T-score − 2.0)

1.4 (0.7–2.9)

0.37

1.4 (0.8–2.3)

0.19

 2 (T-score − 2.5)

2.4 (1.1–5.1)

0.029

1.8 (1.0–3.5)

0.062

 1 (original)b

2.3 (1.0–4.9)

0.039

2.2 (1.2–3.9)

0.008

 2 (original)b

2.4 (1.1–5.2)

0.028

2.2 (1.2–4.0)

0.007

 1 & 2, severe (T-score − 2.0)

1.9 (0.9–4.1)

0.10

2.3 (1.2–4.4)

0.014

 1 & 2, severe (T-score − 2.5)

2.0 (0.8–4.8)

0.12

3.6 (1.6–8.0)

0.002

 1, severe (original)c

3.4 (1.0–11.4)

0.047

5.5 (1.2–24.2)

0.025

 2, severe (original)c

3.4 (1.0–11.4)

0.047

5.5 (1.2–24.2)

0.025

  1. aBarthel index < 100, ADL activities of daily living
  2. bHR Hazard-ratio, OR Odds-ratio, 95% confidence interval, adjusted for cohort and sex
  3. cDiagnostic criteria and cut-offs as published by The European Working Groupon Sarcopenia in Older People 1 and 2 [1, 2] and population-based T-scores (Table 3)